Runnymede Capital Advisors Inc. acquired a new stake in shares of ResMed Inc. (NYSE: RMD) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,837 shares of the medical equipment provider's stock, valued at approximately $1,165,000. Other institutional investors have

GraniteShares Advisors LLC lessened its position in ResMed Inc. (NYSE: RMD) by 90.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 241 shares of the medical equipment provider's stock after selling 2,336 shares during the quarter. GraniteShares Advisors LLC's holdings in

ResMed Inc. (NYSE: RMD - Get Free Report) Director Peter Farrell sold 2,000 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $225.00, for a total transaction of $450,000.00. The transaction was disclosed in a filing with the Securities and Exchange Commission,

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, RL, RMD and GE hold promise.

SG Americas Securities LLC decreased its holdings in ResMed Inc. (NYSE: RMD) by 17.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 46,074 shares of the medical equipment provider's stock after selling 10,027 shares during the quarter. SG Americas Securities

ResMed (RMD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Danske Bank A S acquired a new stake in shares of ResMed Inc. (NYSE: RMD) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 161,546 shares of the medical equipment provider's stock, valued at approximately $44,220,000. Danske Bank A S

Achmea Investment Management B.V. lowered its holdings in ResMed Inc. (NYSE: RMD) by 41.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 138,375 shares of the medical equipment provider's stock after selling 99,277 shares during the quarter. Achmea Investment Management B.V. owned

ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.